abstract |
This application relates to substituted amino six-membered saturated heteroalicyclics shown in general formula I as a long-acting DPP-IV inhibitor, its preparation method, its pharmaceutical composition and its benefit in the treatment and/or prevention of DPP-IV Use in diseases and conditions of IV inhibition. |